Kanta Tsumoto

Prof. Dr. Kanta Tsumoto

Division of Chemistry for Materials, Graduate School of Engineering, Mie University, Tsu, Mie 514-8507, Japan
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2003 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
SNShin-ichiro M. Nomura
Shin-ichiro M. Nomura
Kanta TsumotoKanta Tsumoto
Kanta Tsumoto
THTsutomu Hamada
Tsutomu Hamada
KAKazunari Akiyoshi
Kazunari Akiyoshi
YNYoichi Nakatani
Yoichi Nakatani
Kenichi YoshikawaKenichi Yoshikawa
Kenichi Yoshikawa

1 January 2009 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Kanta TsumotoKanta Tsumoto
Kanta Tsumoto
HMHideki Matsuo
Hideki Matsuo
MTMasahiro Tomita
Masahiro Tomita
TYTetsuro Yoshimura
Tetsuro Yoshimura

7 September 2001 in Langmuir
Verified
Journal Article
Closed access
Kanta TsumotoKanta Tsumoto
Kanta Tsumoto
SNShin-ichiro M. Nomura
Shin-ichiro M. Nomura
YNYoichi Nakatani
Yoichi Nakatani
Kenichi YoshikawaKenichi Yoshikawa
Kenichi Yoshikawa

9 January 2019 in Immunotherapy
Verified
Journal Article
Closed access
Kanta TsumotoKanta Tsumoto
Kanta Tsumoto
YIYushi Isozaki
Yushi Isozaki
HYHisanori Yagami
Hisanori Yagami
MTMasahiro Tomita
Masahiro Tomita
Attention to therapeutic monoclonal antibodies has been dramatically increasing year by year. Their highly specific targeting of antigens can provide very effective medical treatment, and the advent of molecular-targeting medicine is allowing development of a new generation of therapeutic agents. However, there is one critical obstacle to overcome. Most of the established therapeutic monoclonal antibodies have specificity for the primary structures of target antigens, although all proteins harbor original native intact structures for their own specific functions. Stereo-specific monoclonal antibodies recognizing conformational structures of target antigens may thus offer a markedly more versatile approach. Their application may change the very concepts underlying use of therapeutic antibodies.

11 March 2011 in Immunotherapy
Verified
Journal Article
Closed access
MTMasahiro Tomita
Masahiro Tomita
Kanta TsumotoKanta Tsumoto
Kanta Tsumoto
Hybridoma technology features effective usage of innate functions of both immune cells and cancers, allowing production of hybridoma cells, which continuously generate monoclonal antibodies specific to antigens of interest. For standard generation of hybridoma cells, B lymphocytes must be somatically fused with myeloma cells using various technologies. However, the methods generally do not necessarily result in selective fusion of target B lymphocytes with myeloma cells. To overcome this problem, we have developed a new hybridoma technology that involves preselection of B lymphocytes with target antigens based on immunoglobulin receptors and selective fusion of B cell-myeloma cell complexes with electrical pulses. The advanced methodology, termed B-cell targeting, multitargeting and stereospecific targeting, may be applicable to simultaneous production of monoclonal antibodies, selective production of stereospecific monoclonal antibodies, and also to efficient generation of human monoclonal antibodies for clinical purposes.

1 June 2018 in ChemBioChem
Verified
Journal Article
Open access
PDF file
NNNaoki Nakatani
Naoki Nakatani
HSHiroki Sakuta
Hiroki Sakuta
MHMasahito Hayashi
Masahito Hayashi
STShunsuke Tanaka
Shunsuke Tanaka
KTKingo Takiguchi
Kingo Takiguchi
Kenichi YoshikawaKenichi Yoshikawa
Kenichi Yoshikawa
The effect of binary hydrophilic polymers on a pair of representative bio‐macromolecules in a living cell has been examined. The results showed that these bio‐macromolecules exhibited specific localization in cell‐sized droplets that were spontaneously formed through water/water microphase segregation under crowding conditions with coexisting polymers. In these experiments, a simple binary polymer system with poly(ethylene glycol) (PEG) and dextran (DEX) was used. Under the conditions of microphase segregation, DNA was entrapped within cell‐sized droplets rich in DEX. Similarly, F‐actin, linearly polymerized actin, was entrapped specifically within microdroplets rich in DEX, whereas G‐actin, a monomeric actin, was distributed evenly inside and outside these droplets. This study has been extended to a system with both F‐actin and DNA, and it was found that DNA molecules were localized separately from aligned F‐actin proteins to create microdomains inside microdroplets, reflecting the self‐emergence of a cellular morphology similar to a stage of cell division.